The Changing Landscape of Global Vaccine Development and Market Potential - - BioPharm International

ADVERTISEMENT

The Changing Landscape of Global Vaccine Development and Market Potential


BioPharm International
Volume 20, Issue 10

30. Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM. Placebo-controlled Phase III trial of immunologic therapy with metastatic asymptomatic hormone refactory prostate cancer. J Clin Oncol. 2006, 24:3089-3094.

31. Todryk SM, Hill AVS. Malaria vaccines: the stage we are at. Nature Rev Microbiol. 2007;5:487-489.

32. Andersen P. Tuberculosis vaccines—an update. Nature Rev Microbiol. 2007;5:484-486.

33. De Groot AS, McMurry JA. TB vaccine development: opportunity and imperative. In: Moingeon P, editor. Vaccines: Frontiers in Design and Development. Norwich, UK: Horizon Bioscience; 2005. p. 167-182.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
FDA Releases REMS Report
September 25, 2014
Author Guidelines
Source: BioPharm International,
Click here